Successful Treatment of Corticosteroid-Refractory Hypereosinophilia With Reslizumab
Coffey K*, Fajt ML*, Acho M, Gladwin M, Petrov AA
Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA
*Both authors contributed equally to the manuscript.
J Investig Allergol Clin Immunol 2019; Vol 29(3)
Key words: Hypereosinophilia, Treatment, Reslizumab